Heartseed Inc.
219A・Growth Market・Pharmaceuticals
Heartseed Inc.219A
Recent Disclosures
| Date | Type | Title |
|---|---|---|
| 2026-06-12 | Other | Notice Regarding the First Patient Dosed in the Phase I/II company-sponsored Clinical Trial of HS-005 (Catheter Administration) for Cardiac Remuscular |
| 2026-06-12 | Other | 心筋再生医療HS-005（カテーテル投与）の第１／２相治験企業治験における 第１例目実施に関するお知らせ |
| 2026-06-01 | Other | 他家iPS細胞由来心筋球（HS-001）の第I/II相治験（LAPiS試験）解析結果に関するお知らせ |
| 2026-06-01 | Other | Notice Regarding Phase I/II Clinical Trial (LAPiS Study) Analysis Results for Allogeneic iPS Cell-derived Cardiomyocyte Spheroids (HS-001) |
| 2026-05-15 | Earnings Report | 2026年12月期 第１四半期決算短信〔日本基準〕（非連結） |
| 2026-05-15 | Other | Non-consolidated Financial Results for the Three Months Ended March 31, 2026(Under Japanese GAAP) May |
| 2026-04-16 | Other | Notice Concerning Grant of Post-delivery Restricted Stock Units (RSUs) |
| 2026-04-16 | Other | 事後交付型リストリクテッド・ストック・ユニット(RSU)の付与に関するお知らせ |
| 2026-03-27 | Other | 定款 2026/03/27 |
| 2026-03-27 | Other | 事業計画及び成長可能性に関する事項 |